Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04834726 · ClinicalTrials.gov registry record · NA
COVID-19 Vaccine Text Outreach
A NA study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 19,554
- Enrollment target
NCT04834726: Completed NA study, sponsored by University of Pennsylvania.
NCT04834726 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 19,554 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04834726, a NA study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 19,554 participants
- Enrollment target
Study Summary
This project aims to evaluate different approaches to increase COVID-19 vaccine uptake among at-risk patients at Penn Medicine in an equitable and systematic manner through a centralized outreach program. The investigators will evaluate different text-based scheduling and messaging approaches informed by behavioral science to increase uptake among eligible patients, including the use of clinician endorsement, opt-out framing, and scarcity.
Interventions
- BEHAVIORAL Standard Message
- BEHAVIORAL Clinician Endorsement
- BEHAVIORAL Opt-In (Call-Back)
- BEHAVIORAL Opt-in (In-Bound)
- BEHAVIORAL Scarcity
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19,554 participants |
| Start Date | 2021-04-29 |
| Est. Completion | 2021-07-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04834726
The ClinicalTrials.gov registry entry for NCT04834726 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 19,554 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Standard Message is the first listed.
NCT04834726 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04834726 about?
NCT04834726 is a clinical study titled "COVID-19 Vaccine Text Outreach". This project aims to evaluate different approaches to increase COVID-19 vaccine uptake among at-risk patients at Penn Medicine in an equitable and systematic manner through a centralized outreach program. The investigators will evaluate different text-based scheduling and messaging approaches inform...
What is the current status of trial NCT04834726?
This trial is currently completed. It is a NA study. The enrollment target is 19,554 participants. The study started on 2021-04-29. Estimated completion is 2021-07-06.
What interventions are being tested in trial NCT04834726?
The interventions under investigation include: Standard Message (BEHAVIORAL), Clinician Endorsement (BEHAVIORAL), Opt-In (Call-Back) (BEHAVIORAL), Opt-in (In-Bound) (BEHAVIORAL), Scarcity (BEHAVIORAL).
Who is sponsoring clinical trial NCT04834726?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.